With the release of Lower Extremity Amputation, the VQI is now monitoring ten vascular procedures through M2S's PATHWAYS platform. The VQI continues to experience exponential growth since launching in February 2011. Today there are more than 200 participating centers and 1,200 physicians across the United States and Canada capturing and analyzing data in PATHWAYS.
Earlier this month the Initiative announced its collaboration with the American Venous Forum, expanding the VQI to become the comprehensive arterial and venous registry. The first venous procedure module, Inferior Vena Cava Filter, is expected to release into PATHWAYS in February.
PATHWAYS is designed to meet the critical challenges in healthcare, empowering users to collaborate on outcomes and implement quality improvement projects that affect patient care. M2S continually enhances the functionality of PATHWAYS, recently adding risk-adjusted reporting for Carotid Endarterectomy and Carotid Artery Stent to its Analytics and Reporting Engine. Analytics allows users to perform custom, complex outcomes analyses and benchmark their results with peers for comparison. This functionality further increases the value of the data for improving patient care and determining best practices.
M2S, the exclusive technology provider of the Vascular Quality Initiative is a healthcare performance management solutions company that provides innovative technology and services for the healthcare industry to manage clinical information and utilize that information to improve the quality of patient care and reduce costs. The VQI is built on M2S's PATHWAYS clinical data performance platform, allowing users to track, measure, and analyze clinical information, promote collaboration, objectively drive decisions, and optimize performance. For more information, visit www.m2s.com.
Contact: Ashley Legacy, M2S, email@example.com, (603)298-5509